Table 3.

Levels of serum lipids in different groups of experimental mice at the end of the diabetic trial (mean ± SD). Different letters indicate significant differences (p < 0.05 by Duncan’s test) between treatments (n = 6).

Treatment	TC (mmol/L)	TG (mmol/L)	HDL-c (mmol/L)	LDL-c (mmol/L)
DC	3.76 ± 0.19 a	3.09 ± 0.49 a	1.57 ± 0.25 c	0.31 ± 0.05 a
NC	2.64 ± 0.23 bcd	1.48 ± 0.30 c	1.87 ± 0.24 abc	0.20 ± 0.04 cd
EL1	2.39 ± 0.25 cd	1.21 ± 0.21 c	1.95 ± 0.24 abc	0.24 ± 0.04 abcd
EL2	2.08 ± 0.38 d	1.19 ± 0.23 c	2.11 ± 0.21 abc	0.21 ± 0.03 bcd
EL3	2.08 ± 0.15 d	1.15 ± 0.24 c	2.34 ± 0.39 a	0.18 ± 0.02 d
EL4	2.38 ± 0.21 cd	1.02 ± 0.13 c	2.23 ± 0.34 ab	0.23 ± 0.03 abcd
EL5	2.57 ± 0.49 bcd	1.21 ± 0.04 c	2.05 ± 0.31 abc	0.24 ± 0.04 abcd
AL1	2.66 ± 0.42 bcd	1.45 ± 0.37 c	1.66 ± 0.11 c	0.28 ± 0.03 abc
AL2	2.97 ± 0.32 bc	1.41 ± 0.29 c	1.78 ± 0.18 bc	0.28 ± 0.04 abc
AL3	3.03± 0.12 b	1.56 ± 0.16 c	1.74 ± 0.21 bc	0.29 ± 0.05 ab
AL4	3.10 ± 0.42 b	1.24 ± 0.12 c	1.58 ± 0.16 c	0.31 ± 0.04 a
AL5	2.95 ± 0.25 bc	1.29 ± 0.28 c	1.59 ± 0.08 c	0.25 ± 0.04 abcd
MHT	3.00 ± 0.19 b	2.35± 0.29 b	1.70 ± 0.24 bc	0.23 ± 0.02 abcd
XKP	3.12 ± 0.23 b	2.36 ± 0.34 b	1.93 ± 0.18 abc	0.27 ± 0.03 abcd